Casdin Capital, Llc

Casdin Capital, Llc company information, Employees & Contact Information

Casdin Capital, LLC is a New York-based research investment firm focused on the innovations in molecular medicine currently reshaping Life Sciences and healthcare. Founded in 2011, and with an eye to long-term returns and disruptive technologies, Casdin Capital is an expert working with experts, benefiting from its position at the crossroads of the science and investment communities. As trusted investor-partners in both private and public companies, we collaborate with industry leaders to fuel their visions, adding energy, insight, and experience to our over $2.4 billion under management. As we push into new markets and new developments, we stick to our core principles—deep analysis, intellectual honesty, hard work and partnerships with the best people. That approach translates to thousands of conversations with the developers of the drugs, diagnostics, tools and technologies that power this industry, and the data assets and service companies that support the research and product commercialization. In our first ten years, Casdin’s hands-on approach and on-the-ground experience led us to identify the key innovations that are spurring today’s remarkable industry growth. Today, we remain just as focused. Life Sciences and Casdin Capital are just getting started.

Company Details

Employees
47
Founded
-
Address
1350 Avenue Of The Americas,
Phone
+1 212 897 5430
Email
in****@****tal.com
Industry
Financial Services
NAICS
Finance and Insurance
Monetary Authorities-Central Bank
Keywords
New York.
HQ
New York, New York
Looking for a particular Casdin Capital, Llc employee's phone or email?

Casdin Capital, Llc Questions

News

Casdin Capital Leads a Strong Month for Biopharma Funds - Institutional Investor

Casdin Capital Leads a Strong Month for Biopharma Funds Institutional Investor

Fluidigm Announces $250 Million Strategic Capital Infusion - GlobeNewswire

Fluidigm Announces $250 Million Strategic Capital Infusion GlobeNewswire

Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth - Business Wire

Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth Business Wire

Mnemo Therapeutics Announces €75 million Series A to Accelerate Next Generation Integrated CAR-T and Epigenetic Targeting Platform - PR Newswire

Mnemo Therapeutics Announces €75 million Series A to Accelerate Next Generation Integrated CAR-T and Epigenetic Targeting Platform PR Newswire

Top Casdin Capital, Llc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant